Assessment of cardiometabolic risk factors, physical activity levels, and quality of life in stratified groups up to 10 years after bariatric surgery.

• Autor(a) principal: Pereira, Larissa Monteiro Costa
• Data de Publicação: 2019
• Outros Autores: Martins, Felipe José Aidar, Matos, Dihogo Gama de, Farias Neto, Jader Pereira de, Souza, Raphael Fabrício de, Sousa, Antônio Carlos Sobral, Almeida, Rebeca Rocha de, Nunes, Marco Antonio Prado, Silva, Albená Nunes, Silva Júnior, Walderi Monteiro da
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFOP
• Texto Completo: http://www.repositorio.ufop.br/handle/123456789/11942; https://doi.org/10.3390/ijerph16111975
• topic: Health

Obesity is a highly prevalent chronic metabolic disease, with an increasing incidence, and is currently approaching epidemic proportions in developing countries. Ouraim was to evaluate the activity levels, quality of life (QoL), clinical parameters, laboratory parameters, and cardiometabolic risk factors afterbariatric surgery (BS).We classified78 patients who underwentBS into four groups, as follows: Those evaluated 1–2 years after BS (BS2), 2–4 years after BS (BS4), 4–6 years after BS (BS6), and 6–10 years after BS (BS+6). Body weight (BW), body mass index (BMI), comorbidities associated with obesity (ACRO), physical activity level, and QoL were evaluated. Patients exhibited improvements in BW, BMI, cardiometabolic risk, hypertension, dyslipidemia, and diabetes and significant changes in lipid profiles in the first postoperative yearafter BS.The physical activity level inthe BS2, BS4, and BS6 groups was increased, compared with that in the first postoperative year, with a decrease in International Physical Activity Questionnaire scores at 1 year in the BS2 (207.50 30.79), BS4 (210.67 33.69), and BS6 (220.00 42.78) groups. The QoL of patients in theBS2 and BS4 groups was excellent and that of patients in the BS4 and BS+6 groupswas very good. These findings suggest that BS promoted improved physical activity levels and QoL and reduced comorbidities in patients with morbid obesity.